United States · How much has Via Nova Therapeutics raised?
Via Nova Therapeutics has raised $5.0M across 1 round since 2021.
United States · Venture startup
Who invested in Via Nova Therapeutics
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Via Nova Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$5.0Mraised across 1 round since 2021, from 1 source
- Latest round
- Venture, $5.0MSept 2021
- Investors
- 0
The rounds
- Sept 2021Venture$5.0M
No investor was named in the report.
Source recordedSEC filing: $5.0M sold, first sale Aug 2021
Funding filed with regulators
Via Nova Therapeutics filed one raise, $5.0M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Aug 2021$5.0MSEC Form D
Founders and team
From the SEC filings it signed: 1 on the team.
- Donald GanemExecutive Officer, Directori
On the board, as filediBenjamine LiuIlan ZipkinJoseph Jimenez
Quick answers about Via Nova Therapeutics
When did Via Nova Therapeutics last raise?
Via Nova Therapeutics's most recent round was a Venture of $5.0M in Sept 2021.
What was Via Nova Therapeutics's biggest round?
Its most recent round, $5.0M in Sept 2021, is also its largest on record.
What stage is Via Nova Therapeutics at?
Via Nova Therapeutics's latest named round is a Venture, in Sept 2021.
Where is Via Nova Therapeutics based?
Via Nova Therapeutics is based in the United States.
Companies like Via Nova Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.